Literature DB >> 16299299

Sensitization of human aortic endothelial cells to lipopolysaccharide via regulation of Toll-like receptor 4 by bacterial fimbria-dependent invasion.

Hiromichi Yumoto1, Hsin-Hua Chou, Yusuke Takahashi, Michael Davey, Frank C Gibson, Caroline A Genco.   

Abstract

Toll-like receptors (TLRs) are differentially up-regulated in response to microbial infection and chronic inflammatory diseases such as atherosclerosis. Epidemiological data support the idea that periodontal disease may be a risk factor for acceleration of atherosclerosis. Porphyromonas gingivalis, the etiological agent of periodontal disease, invades endothelium, has been detected in human atheromatous tissue, and accelerates atheroma formation in apolipoprotein E-/- mice with concurrent induction of TLRs in the aorta. As endothelial cells can present antigen via TLRs and play an important role in the development of atherosclerosis, we examined TLR expression in human aortic endothelial cells (HAEC) cultured with wild-type P. gingivalis, a fimbria-deficient mutant, and purified antigens. We observed increased TLR expression in HAEC infected with wild-type P. gingivalis by fluorescence-activated cell sorter, but not with noninvasive, fimbria-deficient mutant or purified P. gingivalis antigens. Following a wild-type P. gingivalis challenge, functional TLR2 and TLR4 activation was assessed by subsequent stimulation with TLR agonists Staphylococcus aureus lipoteichoic acid (SLTA; TLR2 ligand) and Escherichia coli lipopolysaccharide (LPS; TLR4 ligand). Unchallenged HAEC failed to elicit monocyte chemoattractant protein 1 (MCP-1) in response to LPS or SLTA but did so when cultured with wild-type P. gingivalis. P. gingivalis-induced TLR2 and -4 expression on HAEC functionally reacted to SLTA and E. coli LPS as measured by a further increase in MCP-1 production. Furthermore, MCP-1 expression elicited by E. coli LPS was inhibitable with TLR4-specific antibody and polymyxin B. These results indicate that invasive P. gingivalis stimulates TLR expression on the surface of endothelium and these primed cells respond to defined TLR-specific ligands.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299299      PMCID: PMC1307031          DOI: 10.1128/IAI.73.12.8050-8059.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

Review 1.  Innate and acquired immunity in atherogenesis.

Authors:  Christoph J Binder; Mi-Kyung Chang; Peter X Shaw; Yury I Miller; Karsten Hartvigsen; Asheesh Dewan; Joseph L Witztum
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

2.  Toll signaling: the TIReless quest for specificity.

Authors:  Jean-Luc Imler; Jules A Hoffmann
Journal:  Nat Immunol       Date:  2003-02       Impact factor: 25.606

3.  Counteracting interactions between lipopolysaccharide molecules with differential activation of toll-like receptors.

Authors:  George Hajishengallis; Michael Martin; Robert E Schifferle; Robert J Genco
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase.

Authors:  Tsuyoshi Shuto; Akira Imasato; Hirofumi Jono; Akihiro Sakai; Haidong Xu; Takahiro Watanabe; Davida D Rixter; Hirofumi Kai; Ali Andalibi; Fred Linthicum; Yue-Ling Guan; Jiahuai Han; Andrew C B Cato; David J Lim; Shizuo Akira; Jian-Dong Li
Journal:  J Biol Chem       Date:  2002-02-26       Impact factor: 5.157

5.  Systemic inflammation in cardiovascular and periodontal disease: comparative study.

Authors:  Ingrid Glurich; Sara Grossi; Boris Albini; Alex Ho; Rashesh Shah; Mohamed Zeid; Heinz Baumann; Robert J Genco; Ernesto De Nardin
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

6.  Dependence of bacterial protein adhesins on toll-like receptors for proinflammatory cytokine induction.

Authors:  George Hajishengallis; Michael Martin; Hakimuddin T Sojar; Ashu Sharma; Robert E Schifferle; Ernesto DeNardin; Michael W Russell; Robert J Genco
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

7.  TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS.

Authors:  Stefanie Zeuke; Artur J Ulmer; Shoichi Kusumoto; Hugo A Katus; Holger Heine
Journal:  Cardiovasc Res       Date:  2002-10       Impact factor: 10.787

8.  Toll-like receptor 4 polymorphisms and atherogenesis.

Authors:  Stefan Kiechl; Eva Lorenz; Markus Reindl; Christian J Wiedermann; Friedrich Oberhollenzer; Enzo Bonora; Johann Willeit; David A Schwartz
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

9.  Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin.

Authors:  Martha M Monick; Timur O Yarovinsky; Linda S Powers; Noah S Butler; A Brent Carter; Gunnar Gudmundsson; Gary W Hunninghake
Journal:  J Biol Chem       Date:  2003-10-17       Impact factor: 5.157

10.  Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation.

Authors:  M Hausmann; S Kiessling; S Mestermann; G Webb; T Spöttl; T Andus; J Schölmerich; H Herfarth; K Ray; W Falk; G Rogler
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

View more
  27 in total

1.  Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses.

Authors:  Chie Hayashi; Andres G Madrigal; Xinyan Liu; Takashi Ukai; Sulip Goswami; Cynthia V Gudino; Frank C Gibson; Caroline A Genco
Journal:  J Innate Immun       Date:  2010-05-10       Impact factor: 7.349

Review 2.  Activation and resolution of periodontal inflammation and its systemic impact.

Authors:  Hatice Hasturk; Alpdogan Kantarci
Journal:  Periodontol 2000       Date:  2015-10       Impact factor: 7.589

3.  NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response.

Authors:  Tie Fu Liu; Vidula T Vachharajani; Barbara K Yoza; Charles E McCall
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

4.  Oxidatively modified low density lipoprotein (LDL) inhibits TLR2 and TLR4 cytokine responses in human monocytes but not in macrophages.

Authors:  Yashaswini Kannan; Kruthika Sundaram; Chandrakala Aluganti Narasimhulu; Sampath Parthasarathy; Mark D Wewers
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

Review 5.  Mechanisms involved in the association between periodontal diseases and cardiovascular disease.

Authors:  R Teles; C-Y Wang
Journal:  Oral Dis       Date:  2011-01-11       Impact factor: 3.511

6.  Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires Toll-like receptor 2-dependent tumor necrosis factor-alpha production.

Authors:  Takashi Ukai; Hiromichi Yumoto; Frank C Gibson; Caroline Attardo Genco
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

7.  Scavenger receptor A is expressed by macrophages in response to Porphyromonas gingivalis, and participates in TNF-alpha expression.

Authors:  M T Baer; N Huang; F C Gibson
Journal:  Oral Microbiol Immunol       Date:  2009-12

8.  Heat-shock protein 60 of Porphyromonas gingivalis may induce dysfunction of human umbilical endothelial cells via regulation of endothelial-nitric oxide synthase and vascular endothelial-cadherin.

Authors:  Cunjin Wu; Shijie Guo; Yuanjie Niu; Limin Yang; Bainian Liu; Ning Jiang; Ming Su; Lin Wang
Journal:  Biomed Rep       Date:  2016-05-27

9.  Immunologic environment influences macrophage response to Porphyromonas gingivalis.

Authors:  G Papadopoulos; Y B Shaik-Dasthagirisaheb; N Huang; G A Viglianti; A J Henderson; A Kantarci; F C Gibson
Journal:  Mol Oral Microbiol       Date:  2016-08-26       Impact factor: 3.563

10.  Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids.

Authors:  Xinyan Liu; Takashi Ukai; Hiromichi Yumoto; Michael Davey; Sulip Goswami; Frank C Gibson; Caroline A Genco
Journal:  Atherosclerosis       Date:  2007-04-26       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.